$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC

2018 Q4 Form 10-Q Financial Statement

#000107997319000060 Filed on February 07, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2017 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $289.6K $810.0K
YoY Change -64.25% 52.83%
% of Gross Profit
Research & Development $114.2K $338.8K
YoY Change -66.29% 168.68%
% of Gross Profit
Depreciation & Amortization $259.00 $436.00
YoY Change -40.6% -13.32%
% of Gross Profit
Operating Expenses $404.1K $1.148M
YoY Change -64.8% 75.69%
Operating Profit -$404.1K -$1.148M
YoY Change -64.8% 75.69%
Interest Expense $97.30K $93.66K
YoY Change 3.89% -0.95%
% of Operating Profit
Other Income/Expense, Net -$97.30K $624.9K
YoY Change -115.57% -760.83%
Pretax Income -$501.3K -$520.0K
YoY Change -3.59% -30.67%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$501.4K -$522.8K
YoY Change -4.11% -30.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$18.98K -$21.46K
COMMON SHARES
Basic Shares Outstanding 24.23M
Diluted Shares Outstanding 26.38M 24.23M

Balance Sheet

Concept 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.32K $30.00K
YoY Change 41.07% 200.0%
Cash & Equivalents $42.32K $28.44K
Short-Term Investments
Other Short-Term Assets $2.610K $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses $1.608K $735.00
Receivables
Other Receivables $1.000K $1.000K
Total Short-Term Assets $44.93K $30.17K
YoY Change 48.91% 77.31%
LONG-TERM ASSETS
Property, Plant & Equipment $1.711K $2.320K
YoY Change -26.25% -28.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.711K $4.897K
YoY Change -65.06% 50.49%
TOTAL ASSETS
Total Short-Term Assets $44.93K $30.17K
Total Long-Term Assets $1.711K $4.897K
Total Assets $46.64K $35.07K
YoY Change 33.0% 73.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $643.7K $930.0K
YoY Change -30.78% 6.9%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00K
YoY Change -100.0% -99.1%
Long-Term Debt Due $9.160M $8.910M
YoY Change 2.81% 2.65%
Total Short-Term Liabilities $10.54M $10.05M
YoY Change 4.84% -32.09%
LONG-TERM LIABILITIES
Long-Term Debt $3.588M $3.470M
YoY Change 3.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.588M $3.470M
YoY Change 3.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.54M $10.05M
Total Long-Term Liabilities $3.588M $3.470M
Total Liabilities $14.12M $13.52M
YoY Change 4.49% -8.66%
SHAREHOLDERS EQUITY
Retained Earnings -$123.1M -$119.7M
YoY Change 2.85% 1.81%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.13M -$13.54M
YoY Change
Total Liabilities & Shareholders Equity $46.64K $35.07K
YoY Change 33.0% 73.0%

Cashflow Statement

Concept 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income -$501.4K -$522.8K
YoY Change -4.11% -30.09%
Depreciation, Depletion And Amortization $259.00 $436.00
YoY Change -40.6% -13.32%
Cash From Operating Activities -$191.7K -$120.0K
YoY Change 59.72% 71.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.93K 140.0K
YoY Change -62.19% 1300.0%
NET CHANGE
Cash From Operating Activities -191.7K -120.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 52.93K 140.0K
Net Change In Cash -138.7K 20.00K
YoY Change -793.65% -133.33%
FREE CASH FLOW
Cash From Operating Activities -$191.7K -$120.0K
Capital Expenditures $0.00
Free Cash Flow -$191.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
1685252
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000
bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
222300
bnet Class Of Warrant Or Right Number For Which Expiration Date Extended
ClassOfWarrantOrRightNumberForWhichExpirationDateExtended
5079188
CY2018 bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2018Q4 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171720
CY2018Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
100000
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
CY2017Q4 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
718580
bnet Interest Expense Related To The Modification Of Warrants
InterestExpenseRelatedToTheModificationOfWarrants
3750
CY2018Q4 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2018Q4 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9160313
bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
CY2013Q2 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
718580
CY2018Q4 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
166776
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
186832
bnet Sale Of Units Value
SaleOfUnitsValue
477365
CY2018Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2018Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9028983
bnet Modification Of Warrants
ModificationOfWarrants
163026
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
477365
CY2017Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
bnet Stock Issued During Period Shares Commissions On Sale Of Units
StockIssuedDuringPeriodSharesCommissionsOnSaleOfUnits
1028
bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
44436
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
4850
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
330000
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
134650
bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
0.96
CY2018Q4 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
90939
CY2017Q4 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
127591
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
785681
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
106204
bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P4Y36D
CY2018Q4 bnet Working Capital
WorkingCapital
10490000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
643707
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
719633
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794149
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794305
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109507489
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108117330
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
118000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6250
CY2018Q4 us-gaap Assets
Assets
46640
CY2018Q2 us-gaap Assets
Assets
31935
CY2018Q4 us-gaap Assets Current
AssetsCurrent
44929
CY2018Q2 us-gaap Assets Current
AssetsCurrent
30487
CY2018Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22013
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72932
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42321
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28436
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20308
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-44496
CY2018Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
698766
CY2017Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
141284
CY2018Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
421641
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16300000
CY2018Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2018Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
174650
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27121371
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25939892
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26996148
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24809841
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24748213
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26417062
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25235583
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26291839
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24105532
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24043904
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div>
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3588130
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3525216
CY2018Q4 us-gaap Depreciation
Depreciation
259
CY2017Q4 us-gaap Depreciation
Depreciation
436
us-gaap Depreciation
Depreciation
695
us-gaap Depreciation
Depreciation
872
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10535186
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10201657
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q4 us-gaap Minority Interest
MinorityInterest
50646
CY2018Q2 us-gaap Minority Interest
MinorityInterest
54338
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
432929
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
203824
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
289599
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
808576
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
967489
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1120693
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1684562
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62989
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
68102
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
355800
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
406800
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5866
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5691
CY2018Q4 us-gaap Interest Expense
InterestExpense
97304
CY2017Q4 us-gaap Interest Expense
InterestExpense
93662
us-gaap Interest Expense
InterestExpense
189800
us-gaap Interest Expense
InterestExpense
192101
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2018Q4 us-gaap Liabilities
Liabilities
14123316
CY2018Q2 us-gaap Liabilities
Liabilities
13726873
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46640
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31935
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-958
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-411663
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-248320
CY2018Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-523
CY2017Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-507
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3692
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1014
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-500831
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-522342
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438205
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1039573
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-97304
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
624918
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-189800
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
526479
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
404050
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
1147767
us-gaap Operating Expenses
OperatingExpenses
1252097
us-gaap Operating Expenses
OperatingExpenses
1567066
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-404050
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1147767
us-gaap Operating Income Loss
OperatingIncomeLoss
-1252097
us-gaap Operating Income Loss
OperatingIncomeLoss
-1567066
us-gaap Other Noncash Expense
OtherNoncashExpense
203632
us-gaap Other Noncash Expense
OtherNoncashExpense
209684
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
44436
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
13508
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
958
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1608
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7474
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
418000
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
452000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
477000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30500
CY2018 us-gaap Profit Loss
ProfitLoss
-3018000
CY2017 us-gaap Profit Loss
ProfitLoss
-2463000
us-gaap Profit Loss
ProfitLoss
-1441897
us-gaap Profit Loss
ProfitLoss
-1040587
CY2018Q4 us-gaap Profit Loss
ProfitLoss
-501354
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-522849
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795860
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1711
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1448
us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
527230
us-gaap Share Based Compensation
ShareBasedCompensation
819698
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7002225
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114192
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
338755
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
283913
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
445501
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123130161
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121691956
CY2018Q4 us-gaap Revenues
Revenues
CY2017Q4 us-gaap Revenues
Revenues
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
325000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.36
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36675
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6827225
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7152225
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.10
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.68
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
23175
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y219D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
150000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.25
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y292D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y182D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
80500
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
175000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.46
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
100000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13904
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-14127322
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13749276
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13694938
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14076676
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26382778
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24233123
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26021264
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24150108
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26382778
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24233123
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26021254
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24150108

Files In Submission

Name View Source Status
0001079973-19-000060-index-headers.html Edgar Link pending
0001079973-19-000060-index.html Edgar Link pending
0001079973-19-000060.txt Edgar Link pending
0001079973-19-000060-xbrl.zip Edgar Link pending
bion_10q-123118.htm Edgar Link pending
bnet-20181231.xml Edgar Link completed
bnet-20181231.xsd Edgar Link pending
bnet-20181231_cal.xml Edgar Link unprocessable
bnet-20181231_def.xml Edgar Link unprocessable
bnet-20181231_lab.xml Edgar Link unprocessable
bnet-20181231_pre.xml Edgar Link unprocessable
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending